David J. Schlanger Sells 56,852 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
David J. Schlanger Sells 56,852 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
Progyny, Inc. (NASDAQ:PGNY – Get Rating) Chairman David J. Schlanger sold 56,852 shares of the stock in a transaction on Thursday, October 6th. The stock was sold at an average price of $40.26, for a total transaction of $2,288,861.52. Following the completion of the sale, the chairman now owns 82,548 shares in the company, valued at $3,323,382.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
納斯達克(股票代碼：PGNY-GET Rating)董事長施蘭格在10月6日星期四的一次交易中出售了56,852股該公司股票。該股以40.26美元的平均價格出售，總成交金額為2288861.52美元。出售完成後，董事長現在擁有該公司82,548股，價值3323,382.48美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過美國證券交易委員會網站.
Progyny Stock Down 6.1 %
Progyny股價下跌6.1%
Shares of PGNY stock opened at $37.51 on Friday. The firm has a fifty day moving average of $40.24 and a 200-day moving average of $37.39. Progyny, Inc. has a 12-month low of $25.67 and a 12-month high of $68.32. The company has a market capitalization of $3.45 billion, a price-to-earnings ratio of 81.54, a P/E/G ratio of 9.49 and a beta of 1.63.
上週五，PGNY股票開盤報37.51美元。該公司的50日移動均線切入位在40.24美元，200日移動均線切入位在37.39美元。Progyny，Inc.的12個月低點為25.67美元，12個月高位為68.32美元。該公司市值為34.5億美元，市盈率為81.54倍，市盈率為9.49倍，貝塔係數為1.63。
Progyny (NASDAQ:PGNY – Get Rating) last issued its quarterly earnings data on Thursday, August 4th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.07. Progyny had a net margin of 7.39% and a return on equity of 17.11%. The company had revenue of $195.00 million during the quarter, compared to the consensus estimate of $190.51 million. During the same quarter in the prior year, the firm earned $0.19 earnings per share. The firm's revenue was up 51.5% compared to the same quarter last year. On average, equities analysts expect that Progyny, Inc. will post 0.2 EPS for the current year.
納斯達克上一次發佈季度收益數據是在8月4日星期四。該公司公佈本季度每股收益(EPS)為0.09美元，比普遍預期的0.02美元高出0.07美元。Progyny的淨利潤率為7.39%，股本回報率為17.11%。該公司本季度的收入為1.95億美元，而市場普遍預期為1.905億美元。去年同期，該公司每股收益為0.19美元。與去年同期相比，該公司的收入增長了51.5%。股票分析師平均預計Progyny，Inc.本年度每股收益將為0.2%。
Analysts Set New Price Targets
分析師設定新的價格目標
Institutional Investors Weigh In On Progyny
機構投資者對Progyny的看法
Large investors have recently made changes to their positions in the stock. National Bank of Canada FI bought a new stake in shares of Progyny during the second quarter worth $29,000. Lazard Asset Management LLC bought a new position in Progyny in the first quarter valued at $62,000. Exane Derivatives bought a new position in Progyny in the first quarter valued at $69,000. Parkside Financial Bank & Trust bought a new position in Progyny in the first quarter valued at $70,000. Finally, Fifth Third Bancorp grew its position in Progyny by 21.4% in the first quarter. Fifth Third Bancorp now owns 1,467 shares of the company's stock valued at $75,000 after purchasing an additional 259 shares in the last quarter. Institutional investors own 88.64% of the company's stock.
大型投資者最近對他們在該股的頭寸進行了調整。加拿大國民銀行FI在第二季度購買了價值2.9萬美元的Progyny新股。Lazard Asset Management LLC在第一季度購買了Progyny的一個新頭寸，價值62,000美元。Exane衍生品公司在第一季度購買了Progyny的一個新頭寸，價值6.9萬美元。Parkside Financial Bank&Trust在第一季度購買了Progyny的一個新頭寸，價值7萬美元。最後，Five Third Bancorp在第一季度將其在Progyny的頭寸增加了21.4%。Five Third Bancorp在上個季度又購買了259股，現在擁有1,467股該公司股票，價值7.5萬美元。機構投資者持有該公司88.64%的股票。
About Progyny
關於Progyny
(Get Rating)
(獲取評級)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Progyny，Inc.是一家福利管理公司，專門為美國僱主提供生育和家庭建設福利解決方案。其生育福利解決方案包括差異化福利計劃設計、個性化禮賓式會員支持服務和有選擇的生育專家網絡。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- 2 Regional Banks With Sector-Beating Price Performance
- MarketBeat: Week in Review 10/3-10/7
- ConAgra Brands Is A Value Pick For Income Investors
- 3 Stocks With Market-Beating Price Performance
- Lucid Motors May Test Investors' Resolve, But Should They Sell?
- 免費獲取StockNews.com關於Progyny的研究報告(PGNY)
- 2家地區性銀行的價格表現優於行業
- MarketBeat：回顧一週10/3-10/7
- 康尼格拉品牌是收益投資者的價值選擇
- 3只股價表現優於大盤的股票
- Lucid Motors可能會考驗投資者的決心，但他們應該出售嗎？
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
接受Progyny Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Progyny和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。